• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (40)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Ataxia  • Neurogenetics  • Review  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Massimo Pandolfo, MD

Arch Neurol. 2008;65(10):1296-1303.

Friedreich ataxia is an autosomal recessive degenerative disease that primarily affects the nervous system and the heart. It is named after its original description as a "degenerative atrophy of the posterior columns of the spinal cord" by Nicholaus Friedreich, who was a professor of medicine in Heidelberg in the second half of the 19th century. The full extent of the Friedreich ataxia phenotype and its genetic epidemiology could only be appreciated after a direct genetic test became available in 1996. At the same time, the complex pathogenesis of Friedreich ataxia started to be unraveled. Herein, I review our current knowledge of the disease and how it is contributing to the development of therapeutic approaches.

Author Affiliations: Service de Neurologie, Erasme Hospital, Brussels Free University, Brussels, Belgium.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2008;65(10):1278-1280.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Primary and Secondary Drug Screening Assays for Friedreich Ataxia
Cotticelli et al.
J Biomol Screen 2012;17:303-313.
ABSTRACT | FULL TEXT  

A practical approach to late-onset cerebellar ataxia: putting the disorder with lack of order into order
van Gaalen and van de Warrenburg
PN 2012;12:14-24.
ABSTRACT | FULL TEXT  

A TAT-Frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model
Vyas et al.
Hum Mol Genet 2011;0:ddr554v2-ddr554.
ABSTRACT | FULL TEXT  

Autosomal recessive cerebellar ataxias: the current state of affairs
Vermeer et al.
J. Med. Genet. 2011;48:651-659.
ABSTRACT | FULL TEXT  

Acute myocardial infarction after botulinum toxin injection
Stahli et al.
QJM 2011;104:615-616.
FULL TEXT  

Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome
Raman et al.
Eur Heart J 2011;32:561-567.
ABSTRACT | FULL TEXT  

Auranofin Protects against Anthrax Lethal Toxin-Induced Activation of the Nlrp1b Inflammasome
Newman et al.
Antimicrob. Agents Chemother. 2011;55:1028-1035.
ABSTRACT | FULL TEXT  

Developments in RNA Splicing and Disease
Poulos et al.
Cold Spring Harb. Perspect. Biol. 2011;3:a000778-a000778.
ABSTRACT | FULL TEXT  

Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin
Condo et al.
Hum Mol Genet 2010;19:1221-1229.
ABSTRACT | FULL TEXT  

Can rehabilitation help ataxia?
Morton and Bastian
Neurology 2009;73:1818-1819.
FULL TEXT  

Recessive twinkle mutations cause severe epileptic encephalopathy
Lonnqvist et al.
Brain 2009;132:1553-1562.
ABSTRACT | FULL TEXT